Full video transcriptClick to expand
Auto-generated transcript of @outrageoustraining's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00God you look so pretty and you tell me that you love me
- 0:06I wish that I could lie but my heart gets in the way
Melanotan II and extreme tanning: what the science says
Quick answer
Melanotan II is a synthetic melanocortin agonist that stimulates diffuse melanin production via MC1R activation, producing UV-independent tanning, an effect confirmed in small clinical trials but never approved for cosmetic use by any major regulatory body. The creator describes an exaggerated hyperpigmentation response consistent with known MT-II pharmacology, but the video includes no mention of concurrent mole changes, side effects, or the absence of medical supervision. This type of unmonitored use is the pattern most commonly associated with adverse dermatological events in the published case literature.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Melanotan II and extreme tanning: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Melanotan II and extreme tanning: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Melanotan II and extreme tanning: what the science says" from Shawn. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Melanotan II is a synthetic melanocortin agonist that stimulates diffuse melanin production via MC1R activation, producing UV-independent tanning, an effect confirmed in small clinical trials but never approved for cosmetic use by any major regulatory body.
The reason this review is not generic is the source wording and the canonical claim label "peptides i ve changed races at this point so everyone knows i m norma." In this clip, the useful excerpt is: "God you look so pretty and you tell me that you love me I wish that I could lie but my heart gets in the way" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against SCENESSE (afamelanotide implant) FDA Prescribing Information (2019), Afamelanotide for Erythropoietic Protoporphyria (2015), and Melanotan II injection resulting in systemic toxicity and rhabdomyolysis (2012), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Melanotan II is a synthetic melanocortin agonist that stimulates diffuse melanin production via MC1R activation, producing UV-independent tanning, an effect confirmed in small clinical trials but never approved for cosmetic use by any major regulatory body.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Melanotan II is a synthetic melanocortin agonist that stimulates diffuse melanin production via MC1R activation, producing UV-independent tanning, an effect confirmed in small clinical trials but never approved for cosmetic use by any major regulatory body. The creator describes an exaggerated hyperpigmentation response consistent with known MT-II pharmacology, but the video includes no mention of concurrent mole changes, side effects, or the absence of medical supervision. This type of unmonitored use is the pattern most commonly associated with adverse dermatological events in the published case literature.
- MT-II has zero FDA approvals as of 2024. Products sold online as MT2 are unregulated research chemicals with no verified purity or standardized concentration.
- Dorr et al. (1998) confirmed MT-II produces real, measurable tanning in fair-skinned people, so the creator's experience is pharmacologically plausible, not fabricated.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MT-II has zero FDA approvals as of 2024. Products sold online as MT2 are unregulated research chemicals with no verified purity or standardized concentration.
- Dorr et al. (1998) confirmed MT-II produces real, measurable tanning in fair-skinned people, so the creator's experience is pharmacologically plausible, not fabricated.
- MT-II binds MC3R and MC4R in addition to MC1R, producing side effects including nausea, flushing, and spontaneous erections that the creator does not mention.
- Rosen et al. (2014, JAMA Dermatology) documented atypical mole changes in MT-II users. Anyone using this compound should have a baseline and follow-up dermatology exam.
- Going 'way too tan' faster than expected is not a sign that a peptide is working well. It is a sign that a potent receptor agonist is active in your body without dose controls.
- No peer-reviewed study has established a safe dosing protocol for MT-II in healthy adults seeking cosmetic tanning. Extrapolating from disease-focused trials is not evidence of safety.
- Regulated telehealth providers offering melanocortin peptides should be able to articulate the melanoma surveillance protocol they use. If they cannot, that is a red flag.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @outrageoustraining actually say?
Honestly, the transcript here is song lyrics, not peptide commentary. The actual substance of this video lives in the caption: the creator claims they went from "albino white" to noticeably, even excessively tan after using Melanotan II (MT2), describing the pigmentation change as dramatic enough that they felt they had "changed races." That's the claim we're fact-checking. There's no dosing advice, no mechanism explanation, just a before-and-after testimonial wrapped in humor. The caption does the talking here.
What they're describing, a dramatic and somewhat uncontrolled hyperpigmentation response, is actually one of the more documented side effects in the Melanotan II literature. So the core claim isn't fabricated. But there's a lot missing from this picture.
Does the science back this up?
Yes, with serious caveats. MT-II is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), and it binds to melanocortin receptors, particularly MC1R and MC3R, stimulating melanin production. The result is diffuse, UV-independent tanning. That part is real and documented.
A 1998 clinical trial by Dorr et al. in the Journal of Investigative Dermatology confirmed that subcutaneous MT-II administration produced significant skin darkening in fair-skinned participants. Hadley and Dorr (2006) in Peptides reviewed melanocortin receptor pharmacology and confirmed MT-II's potency at MC1R. The hyperpigmentation response the creator describes is consistent with these findings. Where it gets complicated is that MT-II also acts on MC3R and MC4R, driving side effects including nausea, spontaneous erections, and facial flushing. The tanning isn't clean. It comes bundled with a full pharmacological package the creator doesn't mention.
What did they get wrong (or right)?
They got the core effect right: MT-II produces dramatic tanning in people with low baseline melanin, and the effect can feel disproportionate. That tracks. Give credit where it's due.
What they glossed over is significant. First, MT-II has never received regulatory approval from the FDA or EMA. It is not a legal prescription drug in the United States. Products sold online as "MT2" exist in a gray market with no quality controls, no standardized dosing, and no verified purity. Second, the uncontrolled pigmentation response the creator describes, being "way too tan," points to a real clinical concern: MT-II can cause existing moles or nevi to darken or change appearance, which raises melanoma surveillance flags. Rosen et al. (2014) in JAMA Dermatology documented cases of atypical mole changes in MT-II users. That's not a footnote. That's a reason to see a dermatologist. The creator frames going "way too tan" as funny. A dermatologist would want to examine those moles.
What should you actually know?
MT-II is not a tanning product you buy at a spa. It's an unregulated research chemical that acts on multiple melanocortin receptors throughout the body. The tanning effect is real but comes with a side effect profile that includes nausea, blood pressure changes, and, most concerning, unpredictable changes to existing pigmented lesions.
If you're considering MT-II through a regulated telehealth platform, understand what the evidence actually supports and what it doesn't. No peer-reviewed study has established a safe, effective dosing protocol for cosmetic tanning in healthy adults. The studies that exist are small, old, or focused on conditions like erythropoietic protoporphyria rather than elective pigmentation. Any platform or provider offering MT-II for cosmetic tanning should be able to explain the melanoma risk, the off-target receptor activity, and why they believe the benefit outweighs the risk for your specific situation. If they can't, that's a problem.
- MT-II is not FDA-approved for any indication as of 2024.
- Unregulated "MT2" products have no guaranteed purity or concentration.
- Existing moles should be monitored by a dermatologist before and during any melanocortin-stimulating therapy.
- The tanning effect is real but so are the cardiovascular and gastrointestinal side effects documented in trials.
Bottom line
The creator's experience is consistent with what the science predicts. That doesn't make it safe or smart. An unverified peptide producing faster-than-expected results isn't a success story, it's a signal that something pharmacologically potent is happening in your body without medical oversight. The "this is nuts" framing in the caption is accurate, just not in the way they meant it.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Shawn · TikTok creator
1.3K views on this video
I’ve changed races at this point. So everyone knows I’m normally ALBINO WHITE lol. Never in my life been tan.. now I’m way to tan lmao. MT2 is nuts. #gym #tan #white #holy #fyp
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about mt-ii has zero fda approvals as of 2024. products sold?
MT-II has zero FDA approvals as of 2024. Products sold online as MT2 are unregulated research chemicals with no verified purity or standardized concentration.
Dorr et al. (1998) confirmed MT-II produces real, measurable tanning in fair-skinned people, so the creator's experience is pharmacologically plausible, not fabricated?
Dorr et al. (1998) confirmed MT-II produces real, measurable tanning in fair-skinned people, so the creator's experience is pharmacologically plausible, not fabricated.
What does the video say about mt-ii binds mc3r?
MT-II binds MC3R and MC4R in addition to MC1R, producing side effects including nausea, flushing, and spontaneous erections that the creator does not mention.
What does the video say about rosen et al. (2014, jama dermatology) documented atypical mole changes?
Rosen et al. (2014, JAMA Dermatology) documented atypical mole changes in MT-II users. Anyone using this compound should have a baseline and follow-up dermatology exam.
What does the video say about going 'way too tan' faster than expected?
Going 'way too tan' faster than expected is not a sign that a peptide is working well. It is a sign that a potent receptor agonist is active in your body without dose controls.
What does the video say about no peer-reviewed study has established a safe dosing protocol for?
No peer-reviewed study has established a safe dosing protocol for MT-II in healthy adults seeking cosmetic tanning. Extrapolating from disease-focused trials is not evidence of safety.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Shawn, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.